undamentalytics Newsletter
Sign in

Impact Biomedical Inc. revenue

Impact Biomedical Inc.'s revenue was $32,000 in fiscal 2025, down 36.0% on the year before. Over the last twelve months it was $35,000.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222025Dec 2025LTMJun 2026
Revenue503235
Growth on the year before—−36.0%—
Gross profit—−392—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Biotechnology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Impact Biomedical Inc. $35,000 — —
Lyell Immunopharma, Inc. $27,000 -55.0% -91.8%
AIM Immunotech Inc. $95,000 -21.5% -17.3%
Ibio, Inc. $100,000 -75.0% -62.4%
Lisata Therapeutics, Inc. $100,000 -90.7% —
Celldex Therapeutics, Inc. $158,000 -97.3% -63.5%

Compare with peers

Head to head: IBO vs LYELAIM vs IBOIBIO vs IBO

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Impact Biomedical Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Impact Biomedical Inc.